Press Releases

February 3, 2025
Press Release

Biosimilar Void is a Crisis in Patient Access According to IQVIA Report

December 18, 2024
Press Release

AAM Comments on End of Year Funding Bill

white house
November 7, 2024
Press Release

AAM & Biosimilars Council Statement on Presidential Election

Capitol at sunet, biosimilar legislation
September 20, 2024
Press Release

Biosimilars Council Urges House to Pass Critical Patent Thicket Legislation

2024 AAM generic & Biosimilar Savings Report
September 5, 2024
Press Release

Biosimilar Medicines Saved $12.4 Billion in 2023

Professional in a laboratory using a microscope.
August 21, 2024
Press Release

Biosimilars Council Submits Comments, Applauds FDA Draft Guidance Regarding Interchangeability

Monoclonal antibodies (Adalimumab)
July 22, 2024
Press Release

PBM Schemes to Control Biosimilar Humira Are Denying Patients Savings – New Analysis Shows PBM Strategies and Brand ‘Product Hopping’ Are Suppressing Uptake of Lower Cost Biosimilar Adalimumab

US Capitol, Build Back Better bill, BBB
July 12, 2024
Press Release

Biosimilars Council Applauds Senate Passage of Cornyn-Blumenthal Patent Thicket Legislation

June 26, 2024
Interchangeability
Press Release

Biosimilars Council Submits Comments to FDA for Promotional Labeling and Advertising Considerations

June 21, 2024
Interchangeability
Press Release

Biosimilars Council Applauds Updated FDA Guidance on Interchangeability

May 30, 2024
Press Release
Streamlining

Biosimilars Council Calls for More Efficient Regulatory Pathways for Critical Medicines

Resources
April 2, 2024
Press Release

PBM Rebate Schemes to Suppress Biosimilar Humira Cost U.S. Patients $6 Billion

March 18, 2024
Press Release

Kentucky Is The Latest State To Enact Legislation To Increase Patient Access To Lower-Cost Biosimilar Medicines

March 13, 2024
Press Release

Biosimilars Council Applauds the President’s Budget Proposal to Eliminate the Arbitrary Distinction between Interchangeable Biologics and Biosimilars

November 27, 2023
Press Release

Biosimilars Council Comments on FDA Draft Guidance on Labeling for Biosimilar and Interchangeable Biosimilar Products

November 9, 2023
Press Release

Biosimilars Council Statement Applauding CMS Proposal to Encourage More Rapid Biosimilar Adoption in Medicare

October 19, 2023
Press Release

Biosimilars Council Statement on the Consideration of the Increasing Access to Biosimilars Act of 2023

July 17, 2023
Press Release

New Data Shows PBMs Blocking Patient Access to Biosimilar Insulin Despite Growing Demand

February 21, 2023
Press Release

Report: Adalimumab Biosimilars Will Increase Competition, but Rebates, Other Barriers Will Impact Savings

January 31, 2023
Press Release

New IQVIA Report: Biosimilars Driving Lower Prices and Greater Savings

December 14, 2022
Press Release

Biosimilars Council Launches Educational Research for Leading Biosimilar Research

November 14, 2022
Press Release

Raising Awareness for Biosimilars for Stakeholders Around the World

September 21, 2022
Press Release

Biosimilar Medicines Generated $7 Billion in Savings in 2021

Senate passes inflation reduction act
August 7, 2022
Press Release

AAM Statement on Senate Passage of Inflation Reduction Act

Inflation reduction act, biosimilars
August 3, 2022
Press Release

Inflation Reduction Act Would Stifle Biosimilar Competition and Savings

US Capitol, Build Back Better bill, BBB
July 7, 2022
Press Release

AAM Statement on BBB 2.0

Federal Trade Commission must investigate PBMs
May 23, 2022
Press Release

AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices

Biosimilars Policy
May 16, 2022
Press Release

Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council

April 1, 2022
Press Release

HHS Finds Biosimilars Use Results in “Significant Spending Reduction” For Medicare and Its Beneficiaries

October 31, 2021
Press Release

Biosimilars Council Encourages Stakeholders, Advocates to Join #GlobalBiosimilarsWeek

September 21, 2021
Press Release

Biosimilar Medicines Produce Billions in Savings in U.S., Dramatically Reduce Oncology Spending Growth: Report

Biosimilars Council - FDA Website Screenshot
July 29, 2021
Press Release

Biosimilars Council Statement on FDA Approval of First Interchangeable Biosimilar

June 17, 2021
Press Release

AAM and Biosimilars Council Statement on ACA Ruling in California v. Texas

A mother and daughter are seated at a table and a doctor is seated across from them.
April 29, 2021
Press Release

Biosimilars Council Endorses The Increasing Access to Biosimilars Act

The White House - Washington DC, United States
April 26, 2021
Press Release

The Biosimilars Council Applauds President Biden for Signing the Advancing Education on Biosimilars Act of 2021

Doctor meets with diabetic senior woman at medical appointment
April 23, 2021
Press Release

The Biosimilars Council Applauds Reintroduction of the Bipartisan BIOSIM Act

March 25, 2021
Press Release

Statement on IQVIA Report: Biosimilars in the U.S.: Reimbursement and Impacts to Uptake

aam policy agenda 117th congress
February 22, 2021
Press Release

AAM Outlines Policy Solutions for Sustained Patient Access to Generic and Biosimilar Medicines

part d statement
January 15, 2021
Press Release

AAM and Biosimilars Council Statement on CMS Decision to Update Part D Program

biosimilars news april 2020
December 10, 2020
Press Release

AAM Statement on President-elect Biden Naming Katherine Tai as U.S. Trade Representative

Xavier Becerra
December 7, 2020
Press Release

AAM Statement on President-elect Biden Naming Xavier Becerra as Secretary of Health and Human Services

igba global biosimilars week
November 15, 2020
Press Release

IGBA Launches First Global Biosimilars Week

FDA-approved biosimilars
November 11, 2020
Press Release

AAM Statement on 2020 Election

IQVIA Biosimilars in the US
October 6, 2020
Press Release

Statement on IQVIA Report: Biosimilars in the U.S. 2020-2024

August 6, 2020
Press Release

Security of the U.S. Pharmaceutical Chain

increasing access to biosimilars act
July 2, 2020
Press Release

Increasing Access to Biosimilars Act

Key Lessons for the US From EU
June 3, 2020
Press Release

Matrix Global Advisors Report Reveals Key Lessons for the United States from Europe’s Biosimilar Experience

February 24, 2020
Press Release

AAM & the Biosimilars Council Applaud FDA’s Release of Enhanced Purple Book

February 5, 2020
Press Release

Statement on CMS Specialty Tier and Generic/Biosimilar Utilization Measures Proposal – Medicare Advantage/Part D NPRM and Advance Notice

biologics market
February 3, 2020
Press Release

Biosimilars Council Statement on FDA & FTC Collaboration to Promote Competition for Biological Products

interchangeable insulin
January 28, 2020
Press Release

AAM’s Biosimilars Council Applauds FDA’s Draft Guidance on Interchangeable Insulin

October 2, 2019
Press Release

Congress’ Bipartisan Efforts to Increase Patient Access to Biosimilars

September 17, 2019
Press Release

Biologics Sign On Letter 2019

September 9, 2019
Press Release

Policy and Market Failures Stifle Biosimilar Adoption in the U.S.

August 26, 2019
Press Release

Statement on Stakeholder Letter to Reduce Medicare Part B Costs for Patients on a Biosimilar

June 25, 2019
Press Release

Patent Thickets Bog Down U.S. Biosimilar Launches

May 30, 2019
Press Release

AAM and the Biosimilars Council Statement on UnitedHealthcare Announcement to Reverse Course on Biosimilars

May 17, 2019
Press Release

AAM and the Biosimilars Council Support Finalization of CMS Part D and Medicare Advantage (MA) Rule

May 13, 2019
Press Release

Press Statement: Biosimilars Council Commends FDA on Insulin Hearing

May 13, 2019
Press Release

AAM and Biosimilars Council Remarks at FDA Biosimilars Public Hearing on Insulin

May 10, 2019
Press Release

AAM and Biosimilars Council Applaud FDA on Interchangeability Guidance

May 8, 2019
Press Release

AAM and the Biosimilars Council Oppose FDA Update to Biosimilar Naming

May 8, 2019
Press Release

Comments of the Association for Accessible Medicines and the Biosimilars Council regarding Nonproprietary Naming of Biological Products: Update; Draft Guidance for Industry; Availability

May 7, 2019
Press Release

Diverse Stakeholder Group Expresses Concern for the Naming of Biological Products

March 6, 2019
Press Release

Association for Accessible Medicines and its Biosimilars Council comments to the FDA on Pfizer’s Citizen Petition

February 23, 2019
Press Release

AAM & Biosimilars Council Response to Pfizer Citizen Petition

February 11, 2019
Press Release

AAM & Biosimilars Council Comments on FDA 2015-D-4750

February 11, 2019
Press Release

AAM & Biosimilars Council Comments on FDA 2011-D-0611

Biosimilars Council - Pharmacists working in Pharmacy
January 22, 2019
Press Release

AAM’s Biosimilars Council Announces 3 New Members

September 21, 2018
Press Release

AAM & Biosimilars Council Comments Regarding FDA-2018-N-2689

Biosimilars Council - Bottles in Automated Processing Facility
September 21, 2018
Press Release

The Association for Accessible Medicines Urges FDA to Foster Biosimilars Competition, Confidence Under Action Plan

Biosimilars Council - Statement Image
September 4, 2018
Press Release

Christine Simmon’s Remarks at FDA Public Hearing on Biosimilars

Biosimilars Council - AAM Call to FDA Press Release - Government Building Against Blue Sky
September 4, 2018
Press Release

Association for Accessible Medicines (AAM) Calls on FDA to Influence Agencies & Congress on Measures to Improve Biosimilar Competition and Lower Costs of Medicine

Biosimilars Council - REMs Press Release Cover Photo - Pill Bottle
September 4, 2018
Press Release

New Study Finds Patients, Government and Insurance Lose $13.4B in Potential Savings By Brand Drug Companies’ Abuses

The Biosimilars Council - U.S.-Mexico Understanding on Biologic Exclusivity
August 28, 2018
Press Release

North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

The Biosimilars Council - Doctor on iPad Abstract
July 18, 2018
Press Release

AAM Statement on FDA’s Biosimilars Action Plan

The Biosimilars Council - 2018 Access and Savings Report Cover Zoomed In
July 10, 2018
Press Release

New Study Finds Biosimilar Competition Can Lower Prescription Drug Costs

Association for Accessible Medicine’s Biosimilars Council Releases Roadmap for Biosimilars Market Development in U.S.
May 30, 2018
Press Release

Association for Accessible Medicine’s Biosimilars Council Releases Roadmap for Biosimilars Market Development in U.S.

The Biosimilars Council - Purple Stethoscope
February 1, 2018
Press Release

IGBA Launches A Biosimilar Medicines Information Campaign

The Biosimilars Council - Researcher with Dropper
January 29, 2018
Press Release

IGBA Congratulates the Australian Government for Maintaining Their Biologics Naming Convention and for Strengthening Pharmacovigilance

The Biosimilars Council - Doctor sitting with older patient
December 4, 2017
Press Release

Poll: Majority of Seniors and Taxpayers Support Lowering Costs and Increasing Access to Medicines Under Medicare Part D

The Biosimilars - Doctor touching ipad
November 2, 2017
Press Release

AAM’S Biosimilars Council Applauds CMS Decision to Revise Biosimilars Reimbursement Policy

The Biosimilars Council - Doctors with hands in the middle
October 4, 2017
Press Release

AAM’S Biosimilars Council Welcomes Boehringer Ingelheim

Biosimilars Council - Statement Image
September 19, 2017
Press Release

Biosimilars Council Supplemental Comments on the CY 2018 Physician Fee Schedule

September 19, 2017
Press Release

New Report Indicates Revising CMS Policy on Biosimilars Could Save $11.4 Billion On Medicines Over 10 Years

The Biosimilars Council - Doctor with Child
September 12, 2017
Press Release

AAM Biosimilars Council Releases 2017 Report on Patient Access to Biosimilars in the US

AAM’s Biosimilars Council Urges CMS to Revise Biosimilars Reimbursement Policy
September 11, 2017
Press Release

AAM’s Biosimilars Council Urges CMS to Revise Biosimilars Reimbursement Policy

September 11, 2017
Press Release

Biosimilars Council Comments on the CY 2018 Physician Fee Schedule

August 3, 2017
Press Release

AAM Statement on Senate Passage of FDA User Fee Reauthorization (FDARA)

July 2, 2017
Press Release

AAM’s Biosimilars Council Praises House Passage of the FDA Reauthorization Act of 2017

June 11, 2017
Press Release
Statement

AAM Biosimilars Council Praises Unanimous Supreme Court Ruling That Will Accelerate Patient Access to Biosimilar Medicines

Biosimilars Council - Statement Image
May 19, 2017
Press Release

AAM & Biosimilars Council Comments on FDA Interchangeability Guidance

The Biosimilar Council
March 20, 2017
Press Release

AAM Biosimilars Council Urges Supreme Court…

(FDA) Biosimilar User Fee Act Public Meeting
March 1, 2017
Press Release

(FDA) Biosimilar User Fee Act Public Meeting

MENU